Extra studies in progress advise that ARV-825 may also be effective in improving the response to estrogen deprivation (aromatase inhibition), another part of standard of care in ER+ breast cancer. - "Our study unveiled the essential job on the KLF16/MYC regulatory axis in modulating tumor growth and chemotherapy sensitivity in https://dominickymyma.daneblogger.com/31364927/the-fact-about-new-advancements-in-brd4-inhibition-therapy-abbv-744-that-no-one-is-suggesting